These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17461890)

  • 1. Levetiracetam: part II, the clinical profile of a novel anticonvulsant drug.
    De Smedt T; Raedt R; Vonck K; Boon P
    CNS Drug Rev; 2007; 13(1):57-78. PubMed ID: 17461890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data.
    De Smedt T; Raedt R; Vonck K; Boon P
    CNS Drug Rev; 2007; 13(1):43-56. PubMed ID: 17461889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam.
    Krishna K; Raut AL; Gohel KH; Dave P
    J Assoc Physicians India; 2011 Oct; 59():656-8. PubMed ID: 22479748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A; Sander JW
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
    Ben-Menachem E; Falter U
    Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
    Welty TE; Gidal BE; Ficker DM; Privitera MD
    Ann Pharmacother; 2002 Feb; 36(2):296-304. PubMed ID: 11847952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
    Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
    Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study.
    Rossetti AO; Jeckelmann S; Novy J; Roth P; Weller M; Stupp R
    Neuro Oncol; 2014 Apr; 16(4):584-8. PubMed ID: 24311644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term continuation of levetiracetam in patients with refractory epilepsy.
    Krakow K; Walker M; Otoul C; Sander JW
    Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of levetiracetam for patients with supratentorial brain tumors.
    Yuan Y; Peizhi Z; Maling G; Wu L; Yunhe M; Xiang W; Qing M; Yanhui L; Ruofei L; Jiewen L
    J Clin Neurosci; 2015 Aug; 22(8):1227-31. PubMed ID: 26051171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
    Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
    Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam as an antiepileptic, neuroprotective, and hyperalgesic drug.
    Cortes-Altamirano JL; Olmos-Hernández A; Bonilla-Jaime H; Bandala C; González-Maciel A; Alfaro-Rodríguez A
    Neurol India; 2016; 64(6):1266-1275. PubMed ID: 27841198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
    von Stuelpnagel C; Holthausen H; Kluger G
    Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.